__CONFIG_widget_menu__{"menu_id":"custom","uuid":"m-170156e432d","dir":"tve_horizontal","dropdown_icon":"style_1","mobile_icon":"style_1","template":"39777","template_name":"Dropdown 01","unlinked":{".menu-item-8":"true"},"icon":{"top":"","sub":""},"top_cls":{"main":"c-underline"},"type":"regular","layout":{"default":"grid"},"actions":[],"images":[],"img_settings":[],"mega_desc":[],"logo":false,"tve_shortcode_rendered":1}__CONFIG_widget_menu__
  • Initiatives
    • Diocare
    • Dioguard
    • Alzheimer's
    • Diabetes
  • News

Latest News


Keep up with the latest news and updates from DIOMICS

Promote Your Most Important Offer Here

This widget allows you to show your most important offer to all visitors.

Call to Action
related posts

A Human Antibody Nasal Spray Under Development Might Have Prevented White House Infections, Scientists At Diomics And Active Motif Say

Read More

Diomics Announces Agreement with Department of Defense to Accelerate Development and Testing of Diocheckâ„¢ SARS-CoV-2 Immune Response Indicator Patch

Read More

Diomics Aims to Nose Out Coronavirus Ahead of Vaccines With Nasal Spray That Delivers Monoclonal Antibody Protection

Read More

Diomics Announces Development Of Diocheckâ„¢ Visual Antibody Indicator

Read More

Get Notified!

Receive an email when we publish a new post

categories
  • Blog
  • News / Press

Press Inquiries

For press inquires email media@diomics.com.

__CONFIG_colors_palette__{"active_palette":0,"config":{"colors":{"62516":{"name":"Main Accent","parent":-1}},"gradients":[]},"palettes":[{"name":"Default Palette","value":{"colors":{"62516":{"val":"var(--tcb-skin-color-0)"}},"gradients":[]}}]}__CONFIG_colors_palette__
FAQ's on Diocheckâ„¢
__CONFIG_colors_palette__{"active_palette":0,"config":{"colors":{"62516":{"name":"Main Accent","parent":-1}},"gradients":[]},"palettes":[{"name":"Default Palette","value":{"colors":{"62516":{"val":"var(--tcb-skin-color-0)"}},"gradients":[]}}]}__CONFIG_colors_palette__
FAQ's on Dioguardâ„¢
October 5, 2020

A Human Antibody Nasal Spray Under Development Might Have Prevented White House Infections, Scientists At Diomics And Active Motif Say

September 16, 2020

Diomics Announces Agreement with Department of Defense to Accelerate Development and Testing of Diocheckâ„¢ SARS-CoV-2 Immune Response Indicator Patch

September 11, 2020

Diomics Aims to Nose Out Coronavirus Ahead of Vaccines With Nasal Spray That Delivers Monoclonal Antibody Protection

August 19, 2020

Diomics Announces Development Of Diocheckâ„¢ Visual Antibody Indicator

February 5, 2020

Diomics Corp. Announces Development of Intellectual Property and Patents Related to the Identification of Airborne Pathogens

January 2, 2020

Diomics Corporation and University of California, Irvine Collaborate to Enable Cell Therapy Clinical Trial for Type 1 Diabetes

Page [tcb_pagination_current_page] of [tcb_pagination_total_pages]

First

Previous

Next

Last

Never miss a good story!

 Subscribe to our newsletter to keep up with the latest trends!

Copyright 2021 Diomics, Inc, all rights reserved. Privacy Policy

call_2_action styled_box guarantee_box